World's Best Scientists 2026 revealed!
Anne-Paule Gimenez-Roqueplo

Anne-Paule Gimenez-Roqueplo

D-Index & Metrics

Medicine

D-Index
79
Citations
29398
World Ranking
17401
National Ranking
579

Anne-Paule Gimenez-Roqueplo publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anne-Paule Gimenez-Roqueplo sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 339 publications — 25th percentile

25% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anne-Paule Gimenez-Roqueplo D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anne-Paule Gimenez-Roqueplo sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 79 D-Index — 14th percentile

14% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anne-Paule Gimenez-Roqueplo is affiliated with Université Paris Cité in France and has a substantial publication record primarily in the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their research focuses extensively on endocrinology, cancer research, surgery, molecular biology, and genetics.

Their work centers on several key topics including:

  • Adrenal and Paraganglionic Tumors
  • Cancer, Hypoxia, and Metabolism
  • Hormonal Regulation and Hypertension
  • Pituitary Gland Disorders and Treatments
  • Neuroblastoma Research and Treatments
  • Metabolomics and Mass Spectrometry Studies
  • Mitochondrial Function and Pathology

Frequent co-authors contributing alongside Anne-Paule Gimenez-Roqueplo include Laurence Amar, Nelly Burnichon, Alexandre Buffet, Judith Favier, and Mercedes Robledo.

Most of their publications appear in the following venues, indicating a focused contribution to endocrinology and clinical sciences:

  • The Journal of Clinical Endocrinology & Metabolism
  • Annales d Endocrinologie
  • Nature Reviews Endocrinology
  • Journal of the Endocrine Society
  • Endocrine Related Cancer

Recent notable publications by Anne-Paule Gimenez-Roqueplo cover a range of topics related to genetic studies and clinical management of pheochromocytoma and paraganglioma, reflecting the integration of genetics with clinical endocrinology:

  • Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension, 2020, Journal of Hypertension
  • An overview of 20 years of genetic studies in pheochromocytoma and paraganglioma, 2020, Best Practice & Research Clinical Endocrinology & Metabolism
  • International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers, 2021, Nature Reviews Endocrinology
  • TET-Mediated Hypermethylation Primes SDH-Deficient Cells for HIF2α-Driven Mesenchymal Transition, 2020, Cell Reports
  • Sino-European Differences in the Genetic Landscape and Clinical Presentation of Pheochromocytoma and Paraganglioma, 2020, The Journal of Clinical Endocrinology & Metabolism

Anne-Paule Gimenez-Roqueplo's work involves cross-disciplinary approaches integrating genetics, molecular biology, and clinical endocrinology to address complex diseases related to adrenal and neuroendocrine tumors. Their prolific output and collaboration network highlight an active role in advancing knowledge on hormonal regulation, genetic mutations, and their implications for diagnosis and treatment.

Best Publications

  • Oncogenic Signaling Pathways in The Cancer Genome Atlas

    Francisco Sanchez-Vega;Marco Mina;Joshua Armenia;Walid K. Chatila

  • Pheochromocytoma and paraganglioma: An endocrine society clinical practice guideline

    Jacques W.M. Lenders;Quan Yang Duh;Graeme Eisenhofer;Anne Paule Gimenez-Roqueplo

  • Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.

    Katherine A. Hoadley;Christina Yau;Christina Yau;Toshinori Hinoue;Denise M. Wolf

  • Comprehensive Characterization of Cancer Driver Genes and Mutations.

    Matthew H Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • Genomic and Functional Approaches to Understanding Cancer Aneuploidy

    Alison M. Taylor;Alison M. Taylor;Juliann Shih;Gavin Ha;Gavin Ha;Galen F. Gao

  • A Call to Action and a Lifecourse Strategy to Address the Global Burden of Raised Blood Pressure on Current and Future Generations: The Lancet Commission on Hypertension

    Michael H. Olsen;Michael H. Olsen;Sonia Y. Angell;Samira Asma;Pierre Boutouyrie

  • Pathogenic Germline Variants in 10,389 Adult Cancers

    Kuan-Lin Huang;R Jay Mashl;Yige Wu;Deborah I Ritter

  • Pheochromocytoma: recommendations for clinical practice from the First International Symposium

    Karel Pacak;Graeme Eisenhofer;Håkan Ahlman;Stefan R Bornstein

  • Genetic Testing in Pheochromocytoma or Functional Paraganglioma

    Laurence Amar;Jérôme Bertherat;Eric Baudin;Christiane Ajzenberg

  • SDHA is a tumor suppressor gene causing paraganglioma

    Nelly Burnichon;Jean-Jacques Brière;Rossella Libé;Laure Vescovo

  • SDH mutations establish a hypermethylator phenotype in paraganglioma.

    Eric Letouzé;Cosimo Martinelli;Cosimo Martinelli;Céline Loriot;Céline Loriot;Nelly Burnichon;Nelly Burnichon

  • Clinical presentation and penetrance of Pheochromocytoma/ Paraganglioma syndromes.

    Diana E. Benn;Anne Paule Gimenez-Roqueplo;Jennifer R. Reilly;Jérôme Bertherat

  • An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis.

    Francien H van Nederveen;José Gaal;Judith Favier;Esther Korpershoek

  • Mutations in the SDHB Gene Are Associated with Extra-adrenal and/or Malignant Phaeochromocytomas

    Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Claudine Rieubland

  • Comprehensive Molecular Characterization of Pheochromocytoma and Paraganglioma

    Lauren Fishbein;Lauren Fishbein;Ignaty Leshchiner;Ignaty Leshchiner;Vonn Walter;Vonn Walter;Ludmila Danilova;Ludmila Danilova

  • Clinical and molecular genetics of patients with the Carney-Stratakis syndrome and germline mutations of the genes coding for the succinate dehydrogenase subunits SDHB, SDHC, and SDHD.

    Barbara Pasini;Sarah R. McWhinney;Thalia Bei;Ludmila Matyakhina

  • Erratum: Comprehensive Characterization of Cancer Driver Genes and Mutations (ARTICLE (2018) 173(2) (371–385), (S009286741830237X), (10.1016/j.cell.2018.02.060))

    Matthew H. Bailey;Collin Tokheim;Eduard Porta-Pardo;Sohini Sengupta

  • The R22X mutation of the SDHD gene in hereditary paraganglioma abolishes the enzymatic activity of complex II in the mitochondrial respiratory chain and activates the hypoxia pathway.

    Anne-Paule Gimenez-Roqueplo;Judith Favier;Pierre Rustin;Jean-Jacques Mourad

  • Succinate Dehydrogenase B Gene Mutations Predict Survival in Patients with Malignant Pheochromocytomas or Paragangliomas

    Laurence Amar;Eric Baudin;Nelly Burnichon;Séverine Peyrard

  • Paraganglioma and phaeochromocytoma: from genetics to personalized medicine

    Judith Favier;Laurence Amar;Anne-Paule Gimenez-Roqueplo

Frequent Co-Authors

Xavier Jeunemaitre
Xavier Jeunemaitre Université Paris Cité
Pierre-François Plouin
Pierre-François Plouin Université Paris Cité
Jérôme Bertherat
Jérôme Bertherat Université Paris Cité
Massimo Mannelli
Massimo Mannelli University of Florence
Felix Beuschlein
Felix Beuschlein University of Zurich
Eric Baudin
Eric Baudin Institut Gustave Roussy
Karel Pacak
Karel Pacak National Institutes of Health
Martin Fassnacht
Martin Fassnacht University of Würzburg
Pierre Corvol
Pierre Corvol Collège de France

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Beyond traditional medical degrees, the healthcare field offers a variety of online programs and flexible career options that support personal and professional goals. For example, those interested in administrative or behind-the-scenes roles may consider accredited medical billing and coding schools with financial aid, which prepare students to manage vital healthcare data and billing processes.

Nursing is another pathway with increasing accessibility. Some nursing programs without teas offer admission without the need for TEAS or HESI exam scores, making entry easier for many aspiring nurses.

For those looking to move into leadership, a degree in healthcare administration prepares graduates for management and organizational roles within medical facilities. Similarly, registered nurses seeking advanced practice options can benefit from adn to fnp programs, which bridge the gap to become family nurse practitioners.

Online degrees and bridge programs provide accessible career ladders across the healthcare sector, helping students align their education with current industry needs.

Best Scientists Citing Anne-Paule Gimenez-Roqueplo

Trending Scientists

Recently Published Articles